Fabtech Technologies Limited
Fabtech Technologies Limited (FABTECH) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Equipment & Supplies›Medical Equipment & Supplies
fabtechnologies.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Sales | 68 Cr | 121 Cr | 63 Cr | 159 Cr | 75 Cr |
| Operating expenses (approx.) | 74 Cr | 91 Cr | 74 Cr | 136 Cr | 71 Cr |
| EBITDA | -6 Cr | 30 Cr | -11 Cr | 22 Cr | 4 Cr |
| OPM % | -9.1% | 25.1% | -18.3% | 14.0% | 5.7% |
| Other income | 0.95 Cr | 3 Cr | 7 Cr | 10 Cr | 3 Cr |
| Interest | 1 Cr | 1 Cr | 0.87 Cr | 0.88 Cr | 0.86 Cr |
| Depreciation | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr |
| Profit before tax | -6 Cr | 31 Cr | -7 Cr | 30 Cr | 5 Cr |
| Tax % | 1.1% | 10.1% | 15.1% | 26.2% | 19.5% |
| Net profit | -6 Cr | 28 Cr | -6 Cr | 22 Cr | 4 Cr |
| EPS (₹) | ₹-1.89 | ₹8.68 | ₹-1.56 | ₹5.75 | ₹0.95 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2026 | TTM |
|---|---|---|
| Sales | 411 Cr | Sign in for TTM |
| Operating expenses (approx.) | 376 Cr | Sign in for TTM |
| EBITDA | 35 Cr | Sign in for TTM |
| OPM % | 8.5% | Sign in for TTM |
| Other income | 21 Cr | Sign in for TTM |
| Interest | 4 Cr | Sign in for TTM |
| Depreciation | 5 Cr | Sign in for TTM |
| Profit before tax | 48 Cr | Sign in for TTM |
| Tax % | 20.5% | Sign in for TTM |
| Net profit | 38 Cr | Sign in for TTM |
| EPS (₹) | ₹10.00 | Sign in for TTM |
| Dividend payout % | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2026 |
|---|---|
| Equity capital | 44 Cr |
| Reserves | 375 Cr |
| Borrowings | 43 Cr |
| Other liabilities | 191 Cr |
| Total liabilities | 654 Cr |
| Fixed assets (net) | 55 Cr |
| CWIP | — |
| Investments | 26 Cr |
| Loans & advances | 0.13 Cr |
| Inventories | 21 Cr |
| Trade receivables | 204 Cr |
| Cash & bank | 87 Cr |
| Other assets | 260 Cr |
| Total assets | 654 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2026 |
|---|---|
| Cash from operating activity | 0.48 Cr |
| Cash from investing | -112 Cr |
| Cash from financing | 190 Cr |
| Net cash flow | 78 Cr |
| Free cash flow (OCF − Capex) | -4 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2026 |
|---|---|
| ROCE % | 11.3% |
| ROE % | 9.1% |
| Debtor days | 181 |
| Inventory days | 19 |
| Days payable | 93 |
| Cash conversion cycle | 107 |
| Debt / equity | 0.10 |
| Current ratio | 2.50 |
| Net debt / EBITDA | -1.26 |
Compare with peers
Loading peers…